Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Equity Average (2022 - 2023)

Bluejay Diagnostics' Equity Average history spans 2 years, with the latest figure at $4.1 million for Q4 2023.

  • On a quarterly basis, Equity Average fell 68.02% to $4.1 million in Q4 2023 year-over-year; TTM through Dec 2023 was $4.1 million, a 68.02% decrease, with the full-year FY2023 number at $7.2 million, down 54.78% from a year prior.
  • Equity Average hit $4.1 million in Q4 2023 for Bluejay Diagnostics, down from $5.8 million in the prior quarter.
  • Over the last five years, Equity Average for BJDX hit a ceiling of $19.4 million in Q1 2022 and a floor of $4.1 million in Q4 2023.